ALLMedicine™ Vitreous Hemorrhage Center
Research & Reviews 412 results
https://clinicaltrials.gov/ct2/show/NCT04444492
May 11th, 2022 - Retinal vein occlusion (RVO) is the second most common retinal vascular disease leading to visual impairment. Main cause for visual impairment in CRVO (Central Retinal Vein Occlusion) is macular edema (ME) while neovascularization of the retina an...
https://doi.org/10.1016/j.jaapos.2022.02.007
Journal of AAPOS : the Official Publication of the Americ... Mudri J, Warne R et. al.
May 8th, 2022 - We present a case of bilateral myelin oligodendrocyte glycoprotein antibody optic neuritis (MOG-ON) with unilateral vitreous hemorrhage in a 6-year-old boy. Multidisciplinary team care, including extensive investigations and prolonged follow-up, e...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9080970
European Journal of Ophthalmology; Casarini B, Bruni F et. al.
May 5th, 2022 - To report a case of possible multi-district thromboembolic event involving the eye of a patient with several cardiovascular risk factors, following a second inoculation of SARS-CoV-2 m-RNA based vaccine. A 60-year-old man presented with blurred vi...
https://doi.org/10.1097/ICB.0000000000001247
Retinal Cases & Brief Reports; Yu JJ, Adrean SD
Apr 22nd, 2022 - To describe cases of visually significant vitreous hemorrhage (VH) following dexamethasone (DEX) intravitreal implant in our practice and present two cases which required surgical intervention as well as a case of VH and hypotony following DEX imp...
https://doi.org/10.1186/s12886-022-02405-y 10.4103/0301-4738.31936 10.1080/09273948.2016.1196713 10.1080/09273948.2017.1335755 10.1097/IIO.0b013e3181d2cc6b 10.1371/journal.pone.0237995 10.1016/j.ajo.2005.03.057 10.1136/bjo.2007.133967 10.1016/j.ophtha.2013.02.020 10.1016/j.ajo.2019.10.031 10.1016/S0161-6420(93)31469-7 10.1007/s00417-004-0973-0 10.1080/09273940902957305 10.1038/eye.2008.31 10.1016/j.ophtha.2008.05.022 10.1016/s0161-6420(02)01033-3 10.3980/j.issn.2222-3959.2014.03.33 10.1136/bjo.2009.167940 10.1186/s12886-018-0838-7 10.1007/s10384-012-0150-7 10.1016/s0161-6420(99)00133-5 10.1016/j.ajo.2005.05.032 10.1097/iae.0000000000002372 10.1159/000500238 10.1016/j.ajoc.2020.100768 10.1016/j.ophtha.2009.06.043 10.1016/j.ajo.2015.09.024 10.1038/eye.2015.275 10.1186/s12886-017-0585-1 10.1155/2018/7643174 10.1080/09273948.2020.1859257 10.1111/aos.13015 10.1016/j.ajo.2006.04.016 10.1371/journal.pone.0052385 10.3109/02713689209001814 10.1097/00055735-200212000-00012
BMC Ophthalmology; Sakai A, Tagami M et. al.
Apr 21st, 2022 - Diagnostic vitrectomy is an important method for evaluating uveitis, and its diagnostic utility is high regardless of whether the uveitis is infectious or non-infectious. The course of diagnostic vitreous surgery with 27-gauge pars plana vitrectom...
Clinicaltrials.gov 23 results
https://clinicaltrials.gov/ct2/show/NCT04444492
May 11th, 2022 - Retinal vein occlusion (RVO) is the second most common retinal vascular disease leading to visual impairment. Main cause for visual impairment in CRVO (Central Retinal Vein Occlusion) is macular edema (ME) while neovascularization of the retina an...
https://clinicaltrials.gov/ct2/show/NCT05318742
Apr 8th, 2022 - Enrolled patients will be randomized into 1 of 2 possible treatment groups: Group A patients underwent endolaser PRP with a range of 200-300 shots during PPV, whereas Group B patients underwent endolaser PRP with a range of 500-600 shots during PP...
https://clinicaltrials.gov/ct2/show/NCT05138029
Mar 8th, 2022 - Test method: Include suitable cases of diabetic retinopathy and macular edema Inclusion criteria: a. PDR patients with severe vitreous hemorrhage who cannot collect oct images and require vitrectomy b. Type 2 diabetes, aged 18~80 years old c. Good...
https://clinicaltrials.gov/ct2/show/NCT02590094
Dec 3rd, 2021 - Severe vision loss in patients with proliferative diabetic retinopathy (PDR) frequently results from complications related to neovascularization and fibrovascular proliferation. Patients with PDR are typically considered candidates for pars plana ...
https://clinicaltrials.gov/ct2/show/NCT04380077
Dec 2nd, 2021 - Subjects enrolled into the study are randomized into one of the ensuing treatment cohorts: Group A patients undergo vitreous substitution with 20-30% sulfur hexafluoride (SF6) gas during PPV, whereas Group B patients undergo vitreous substitution ...
News 37 results
https://www.medscape.com/viewarticle/971155
Mar 29th, 2022 - A New York appeals court has upheld a $1.2 million verdict against an eye surgeon after his patient went blind after cataract removal and lens replacement surgery. Carola Rozon visited New York ophthalmologic surgeon Edwin Schottenstein, MD, in 20...
https://www.medscape.com/viewarticle/947651
Mar 19th, 2021 - In most clinical practices, floaters related to a posterior vitreous detachment are a common patient concern, especially in those with advancing age. Fortunately, floaters often become less symptomatic with time, and very few patients ultimately r...
https://www.medscape.com/viewarticle/943374
Dec 30th, 2020 - In the treatment of vitreous hemorrhage from proliferative diabetic retinopathy, intraocular injection with anti–vascular endothelial growth factor (VEGF) shows similar efficacy to that of vitrectomy with photocoagulation; however, patients common...
https://www.medscape.com/viewarticle/926273
Mar 5th, 2020 - FROM THE LANCET DIABETES & ENDOCRINOLOGY The risk for microvascular complications in adults with latent autoimmune diabetes increases the longer they have the disease, according a post hoc analysis of a large European database. However, Ernesto Ma...
https://www.mdedge.com/endocrinology/article/218320/diabetes/latent-diabetes-warrants-earlier-tighter-glycemic-control
Richard Mark Kirkner
Mar 3rd, 2020 - The risk for microvascular complications in adults with latent autoimmune diabetes increases the longer they have the disease, according a post hoc analysis of a large European database. However, Ernesto Maddaloni, MD, of Sapienza University of Ro.
